SEngine Precision Medicine Company

SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.

Last Funding Type: Series A
Funding Status: Early Stage Venture
Headquarters: Seattle, Washington, United States
Founded Date: 2015-01-01
Last Funding Date: 2022-07-28
Total Funding: 21200000.0
Technology: Biotechnology
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investors Number: 5.0
Industry: Early Drug Development